RPL38P2

Across TCGA pan-cancer cohorts, RPL38P2 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated RPL38P2 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher RPL38P2 RNA is associated with better overall survival. In most high-consensus cancer types, elevated RPL38P2 expression acts as an unfavorable survival marker, although some lineages such as KIRP and BLCA show a favorable association.

KIRP, BLCA, and ACC are the cancer types where RPL38P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Quartile	II,III,IV	0.859	0.409	<.001	64	view →
BLCA	OS	Median	All	0.561	0.318	.001	59	view →
ACC	OS	Quartile	All	0.274	0.704	.005	50	view →
UCS	DFS	Median	IV	0.367	0.952	.001	42	view →
LIHC	OS	Median	All	0.419	0.664	.006	37	view →
KICH	OS	Tertile	II,III,IV	0.468	1.000	.006	27	view →
THYM	OS	Tertile	IV	0.294	1.000	.025	21	view →
LUSC	DFS	Quartile	III,IV	0.119	0.806	<.001	14	view →
CHOL	DFS	Tertile	III,IV	1.000	0.182	.034	9	view →
READ	DFS	Tertile	III,IV	0.824	0.455	.016	8	view →
THCA	OS	Median	III,IV	1.000	0.949	.009	7	view →
TGCT	DFS	Quartile	II,III,IV	0.729	0.996	.049	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

RPL38P2–KIRP (OS)

Open the KIRP breakdown →